Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Daly Insider Profile
4 Followers
David Daly, CCO at Foundation Medicine, holds 17.18K shares in NeoGenomics (Ticker: NEO), holds 45.63K shares in Foundation Medicine (Ticker: FMI), holds ― shares in Singular Genomics Systems (Ticker: OMIC).
David Daly Foundation Medicine (FMI)CCO
Foundation Medicine (FMI)
CCO
Not Ranked
David Daly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Daly holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Daly
David Daly's Trading History
Foundation Medicine
Jul 07, 2017
―
Uninformative Sell
245.31K
$6.25M
NeoGenomics
Jun 14, 2022
Director
Uninformative Buy
―
$281.91K
Singular Genomics Systems
―
President and Chief Operating
―
―
List of latest transactions for each holding click on a transaction to see David Daly's performance on stock
You May Also Like
David Daly insider profile FAQ
What is the percentage of profitable transactions made by David Daly?
The percentage of profitable transactions made by David Daly is ―.
What is the average return per transaction made by David Daly?
The average return per transaction made by David Daly is ―.
What stocks does David Daly hold?
David Daly holds: FMI, NEO, OMIC stocks.
What was David Daly’s latest transaction?
David Daly latest transaction was an Uninformative Buy of ―.
What was David Daly's most profitable transaction?
David Daly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Daly's role in Foundation Medicine?
David Daly's role in Foundation Medicine is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.